Citalopram study shows no autism benefits

WSJ

A study, published June 1, 2009 in the Archives of General Psychiatry, showed that the popularly prescribed antidepressant, citalopram, did not “reduce repetitive behaviors that are a key characteristic of autism and are a significant reason why this class of antidepressants is prescribed.”

For full report, read the full article published in the Wall Street Journal.

Nationwide research finds that citalopram is no more effective than a placebo and that its side effects are twice as bad. About a third of autistic kids take the drug, known as Celexa in the U.S.

For full report, read the full article published in the Los Angeles Times